XTL BIOPHARMACEUTICALS LTD. Form 6-K: Report of foreign private issuer
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2022-11-29: Form 6-K; Period of report 2022-11-29; Description REPORT OF FOREIGN PRIVATE ISSUER; Document ea169385-6k_xtlbiopharma.htm.
- 2022-08-24: Form 6-K; Period of report 2022-06-30; Description REPORT OF FOREIGN PRIVATE ISSUER; Document ea164763-6k_xtlbio.htm.
- 2022-06-01: Form 6-K; Period of report 2022-06-01; Description REPORT OF FOREIGN PRIVATE ISSUER; Document ea160779-6k_xtlbiophar.htm.
- 2022-01-26: Form 6-K; Period of report 2022-01-26; Description FORM 6-K; Document ea154518-6k_xtlbiophar.htm.
| Filed | Form | Period of report | Description | Document |
|---|---|---|---|---|
| 2022-11-29 | 6-K | 2022-11-29 | REPORT OF FOREIGN PRIVATE ISSUER | ea169385-6k_xtlbiopharma.htm |
| 2022-08-24 | 6-K | 2022-06-30 | REPORT OF FOREIGN PRIVATE ISSUER | ea164763-6k_xtlbio.htm |
| 2022-06-01 | 6-K | 2022-06-01 | REPORT OF FOREIGN PRIVATE ISSUER | ea160779-6k_xtlbiophar.htm |
| 2022-01-26 | 6-K | 2022-01-26 | FORM 6-K | ea154518-6k_xtlbiophar.htm |
| 2022-01-19 | 6-K | 2022-01-19 | FORM 6-K | ea154180-6k_xtlbiopharma.htm |